Pena Clarissa, Moustafa Abdelmoniem, Mohamed Abdel-Rhman, Grubb Blair
Department of Internal Medicine, University of Toledo, Toledo, OH 43614, USA.
Division of Cardiovascular Medicine, University of Toledo, Toledo, OH 43614, USA.
J Pers Med. 2024 Apr 20;14(4):435. doi: 10.3390/jpm14040435.
Orthostatic intolerance is a broad term that represents a spectrum of dysautonomic disorders, including postural orthostatic tachycardia syndrome (POTS) and orthostatic hypotension (OH), as manifestations of severe autonomic failure. While the etiology of orthostatic intolerance has not yet fully been uncovered, it has been associated with multiple underlying pathological processes, including peripheral neuropathy, altered renin-aldosterone levels, hypovolemia, and autoimmune processes. Studies have implicated adrenergic, cholinergic, and angiotensin II type I autoantibodies in the pathogenesis of orthostatic intolerance. Several case series have demonstrated that immunomodulation therapy resulted in favorable outcomes, improving autonomic symptoms in POTS and OH. In this review, we highlight the contemporary literature detailing the association of autoimmunity with POTS and OH.
直立不耐受是一个广义术语,代表一系列自主神经功能障碍,包括体位性直立性心动过速综合征(POTS)和直立性低血压(OH),是严重自主神经功能衰竭的表现。虽然直立不耐受的病因尚未完全明确,但它与多种潜在病理过程相关,包括周围神经病变、肾素 - 醛固酮水平改变、血容量不足和自身免疫过程。研究表明,肾上腺素能、胆碱能和血管紧张素II 1型自身抗体与直立不耐受的发病机制有关。多个病例系列已证明免疫调节治疗产生了良好效果,改善了POTS和OH患者的自主神经症状。在本综述中,我们重点介绍了详述自身免疫与POTS和OH之间关联的当代文献。